TET1 c.3853C>A ;(p.Q1285K)

Variant ID: 10-70406339-C-A

NM_030625.2(TET1):c.3853C>A;(p.Q1285K)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer.

Plos One
Janjigian, Yelena Y YY; Vakiani, Efsevia E; Ku, Geoffrey Y GY; Herrera, Jessica M JM; Tang, Laura H LH; Bouvier, Nancy N; Viale, Agnès A; Socci, Nicholas D ND; Capanu, Marinela M; Berger, Michael M; Ilson, David H DH
Publication Date: 2015

Variant appearance in text: TET1: 3853C>A; Q1285K
PubMed Link: 26275293
Variant Present in the following documents:
  • pone.0134731.s005.xls, sheet 1
View BVdb publication page